| Ticker Details |
|
Septerna, Inc. Common Stock
|
| IPO Date: |
October 25, 2024 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.22B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.61 | 3.79%
|
| Avg Daily Range (30 D): |
$0.90 | 3.41%
|
| Avg Daily Range (90 D): |
$0.77 | 3.05%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
.23M |
| Avg Daily Volume (90 D): |
.24M |
| Trade Size |
| Avg Trade Size (Sh.): |
74 |
| Avg Trade Size (Sh.) (30 D): |
50 |
| Avg Trade Size (Sh.) (90 D): |
52 |
| Institutional Trades |
| Total Institutional Trades: |
176 |
| Avg Institutional Trade: |
$1.76M |
| Avg Institutional Trade (30 D): |
$1.5M |
| Avg Institutional Trade (90 D): |
$1.4M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.8M |
| Avg Closing Trade (30 D): |
$.79M |
| Avg Closing Trade (90 D): |
$1.01M |
| Avg Closing Volume: |
90.04K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$13.75
|
$.18
|
$-.56
|
|
Diluted EPS
|
$13.75
|
$.18
|
$-.56
|
|
Revenue
|
$22.05M
|
$21.5M
|
$.12M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-58.81M
|
$8.17M
|
$-24.84M
|
|
Operating Income / Loss
|
$-76.99M
|
$2.61M
|
$-28.98M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$231.75M
|
$130.68M
|
$-20.73M
|
|
PE Ratio
|
2.24
|
|
|
|
|
|